Noriaki Yoshida

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Tayla B. Heavican, Alyssa Bouska, Jiayu Yu et al. · Blood · 2019 · 275 citations · Full text

Medicine, Molecular Genetics, Oncology +17

PD-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for adult T-cell leukemia/lymphoma

Hiroaki Miyoshi, Junichi Kiyasu, Takeharu Kato et al. · Blood · 2016 · 128 citations

Medicine, Immunology, Oncology +16

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models

Samuel Y. Ng, Noriaki Yoshida, Amanda L. Christie et al. · Nature Communications · 2018 · 114 citations · Full text

Medicine, Oncology, Pharmacology +12

Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients

Keisuke Kawamoto, Hiroaki Miyoshi, Noriaki Yoshida et al. · The American Journal of Surgical Pathology · 2016 · 108 citations

Medicine, Oncology, Pathology +17

The role of an anti‐myeloperoxidase antibody in the diagnosis and classification of acute leukaemia: a comparison with light and electron microscopy cytochemistry

Valéria Buccheri, V. Shetty, Noriaki Yoshida et al. · British Journal of Haematology · 1992 · 73 citations

Medicine, Hematology, Pathology +14